Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New shoulder implant aims to stop rotator cuff tears from returning

NCT ID NCT06741527

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a device called the Integrity Implant System to see if it helps people with torn rotator cuffs heal better after surgery. The implant is used to support the repair and reduce the chance of the tear coming back. About 150 adults will take part, and their progress will be tracked for a year using MRI scans and shoulder function tests.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Integrity Implant System (a surgical device used to support rotator cuff repair)
What this could lead to
If successful, this device could lower the chance of rotator cuff tears coming back after surgery, helping people recover better.
What could go wrong
This is a single-arm study without a comparison group, so results may be less reliable. The device may not reduce re-tear rates as hoped, and surgery always carries risks like infection or implant failure.
Why investors are watching

Anika Therapeutics is running a post-market study of its Integrity Implant System for rotator cuff tear augmentation, a procedure that reinforces torn shoulder tendons. For a small company, this trial serves as a confirmatory check on a product already in use, and the results could shape how surgeons and payers view the device. A clear demonstration of safety and benefit matters because the company's size means one product's reputation can carry outsized weight.

If it works: A positive result could strengthen confidence in the Integrity Implant System and support broader adoption among shoulder surgeons. That could translate into steadier sales of the device, which would be meaningful for a company with a limited product lineup.

If it fails: If the study shows weak performance, safety concerns, or fails to confirm clinical benefit, it could hurt the product's reputation and sales. Trials also face delays or enrollment problems, and failure is common in medical studies, so a negative or inconclusive readout is a real possibility.

AI-written from the trial record. Speculative, and not investment advice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 150 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2025

Expected to finish

Oct 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

1. At least 18 years of age 2. Able (with assistance from LAR, if necessary) to understand the informed consent process, including regulatory requirements such as HIPAA authorization, and document informed consent prior to completion of any study-related procedures. 3. Able to complete all Patient Reported Outcome Measure (PROM) questionnaires. 4. Fully understands study requirements and able to return for all required follow-up visits and assessments. 5. Able to comply with all post-operative physician prescribed rehabilitation instructions. 6. Index shoulder rotator cuff tendon tear surgical access may be performed using mini-open, single-portal arthroscopic or multi-portal arthroscopic intervention 7. Meets all intended use and indications for use defined within the Integrity Implant System IFUs as applied to rotator cuff tendon tears. These include: Index shoulder rotator cuff tendon tear needs management and protection from injury Index shoulder has no substantial loss of tendon tissue Index shoulder rotator cuff tendon tear footprint allows approximation of soft tissue and fixation of the Integrity Implant to tendon tissue using an Integrity Tissue Tack Index shoulder rotator cuff tendon tear footprint allows fixation of the Integrity Implant to bone using the Integrity Bone Staple Exclusion Criteria The subject exclusion criteria are as follows: 1. Medical condition that in the PI's opinion would place the subject at risk or interfere with the study 2. Vulnerable population (prisoners, minors, pregnant women, mentally ill persons and the elderly or any person under any undue pressure from others to participate in the study) 3. Pregnant, breastfeeding, or plans to become pregnant during the study 4. History of poor compliance with medical treatment of any kind 5. Deemed contraindicated for MRI by the PI 6. Previous rotator cuff surgery (any type) on the index shoulder 7. Current instability of the index shoulder 8. Rotator cuff tendon tear is a Massive Cofield Classified Full-Thickness Tear (tear length \>5cm) 9. Chondromalacia of index shoulder ≥ Grade 3 10. Fatty infiltration of the index shoulder rotator cuff muscle ≥ Grade 3 11. Insulin dependent Type I Diabetes 12. History of heavy smoking (≥ 1 pack per day) within last 6-months 13. History of auto-immune or immunodeficiency disorders 14. Currently taking immunosuppression medication for other diseases (e.g., transplants or other inflammatory diseases) 15. Oral steroid use in the last 2-months or injectable steroid use in the last 3-months 16. History of cognitive or mental health status that interferes with study participation 17. Poor comprehension of English language 18. Meets one or more of the contraindications defined within the Integrity Implant System IFUs as applied to rotator cuff tendon tears. These include: 18.1 Rotator cuff tendon tear is deemed irreparable by the PI 18.2 Rotator cuff tendon tear repair requires replacement of damaged tendon 18.3 Rotator cuff tendon tear repair requires fixation of soft tissue to adjoining soft tissue 18.4 Rotator cuff tendon tear repair requires tendon strength reinforcement 18.5 Presence of infection 18.6 Any condition which would limit the ability or willingness to restrict activities or follow directions during the healing period 18.7 Hypersensitivity to any of the Integrity Implant System components 18.8 Inadequate soft tissue support for Integrity Tissue Tack fixation 18.9 Inadequate quality of bone for Integrity Bone Staple fixation

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Rotator cuff tears of the shoulder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    9 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Campbell Clinic

    RECRUITING

    Germantown, Tennessee, 38138, United States

  • Central Indiana Orthopaedics

    RECRUITING

    Fishers, Indiana, 46037, United States

  • Foundation for Orthopaedic Research and Education

    RECRUITING

    Tampa, Florida, 33607, United States

  • Harbin Clinic

    RECRUITING

    Rome, Georgia, 30165, United States

  • OrthoArizona

    RECRUITING

    Gilbert, Arizona, 85234, United States

  • Premier Orthopaedic Trauma Specialists, PMC

    RECRUITING

    Pomona, California, 91767, United States

  • Steadman Hawkins Clinic of the Carolinas

    RECRUITING

    Greenville, South Carolina, 29615, United States

  • Towson Orthopaedic Associates/University of Maryland St. Joseph's Medical Center

    RECRUITING

    Towson, Maryland, 21204, United States

  • Virtua Health

    RECRUITING

    Marlton, New Jersey, 08053, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.